Characterization of Dog Allergens Can f 1 and Can f 2. 1. Preparation of Their Recombinant Proteins and Antibodies
1. Preparation of Their Recombinant Proteins and AntibodiesKamata Y.a · Miyanomae A.a · Nakayama E.a · Miyanomae T.b · Tajima T.a · Hoshi H.a
aGraduate School of Life and Environmental Sciences, Osaka Prefecture University, Sakai, and bNational Hospital Organization, Minami-Kyoto Hospital, Kyoto, Japan
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Background: Recombinant dog allergens, rCan f 1 and rCan f 2, and their antibodies are good tools for the characterization of dog allergens in order to develop modern therapeutic and preventive methods for dog allergy. Methods: In this study, cDNA was synthesized from the mRNA of dog salivary glands and cloned into the pGEX4T vector. rCan f 1 and rCan f 2 containing glutathione S-transferase were prepared by an Escherichia coli expression system. The antibodies against the recombinant allergens were prepared in rabbit. The serum of patients with dog allergy was evaluated by ELISA and immunoblot, using the recombinant allergens, goat anti-human immunoglobulin (Ig) E (Ε) labeled with biotin, and enzyme-labeled streptavidin. The binding of IgE in the serum of patients with dog allergy to dog saliva as a natural antigen was determined in the presence or absence of dog saliva, rCan f 1 and rCan f 2 as competitors. The anaphylactic potential of rCan f 1 and rCan f 2 was evaluated. The body temperature of the mice sensitized with rCan f 1 and rCan f 2 was monitored after intravenous injection of the allergens. The passive cutaneous anaphylaxis reaction was examined for rCan f 1 and rCan f 2. Dog salivary glands, dog saliva and dog hair/dander extracts were analyzed with antibodies by means of an immunoblot assay. The expression of the mRNA of Can f 1 and Can f 2 was verified in various dog tissues by reverse transcription polymerase chain reaction. Results: The E. coli expression system revealed the yield of rCan f 1 and rCan f 2 in 36 and 30 mg/l of culture. The molecular weights of rCan f 1 and rCan f 2 were 18 and 20 kDa in SDS-PAGE, respectively. rCan f 1 and rCan f 2 were found to bind to specific IgE in the serum of dog allergy patients. The binding of IgE in the patient serum for dog saliva was partially inhibited in the presence of rCan f 1 and rCan f 2. These recombinant allergens showed positive signals in passive cutaneous anaphylaxis reaction and induced anaphylactic shock in the mouse model, resulting in a decrease in body temperature. The polyclonal rabbit antibody for rCan f 1 bound to a protein of 20 kDa in the salivary gland, saliva and hair/dander extracts of dogs. The rabbit antibody for rCan f 2 bound to proteins in the saliva and the hair/dander extracts. The proteins possessed a molecular weight of 22/ 23 kDa. Reverse transcription polymerase chain reaction showed the presence of mRNA expression of Can f 1 and Can f 2 not only in the salivary gland but also in dog skin. A clear expression of Can f 2 mRNA was observed in dog skin. Conclusions: The recombinant allergens and antibodies for Can f 1 and Can f 2 are available for immunological and biochemical characterization of dog allergens. The molecular weight of the natural Can f 1 and Can f 2 in dog saliva and hair/dander extracts showed a higher molecular weight than that of rCan f 1 and rCan f 2. The significance of dog skin as the tissue producing dog allergens, especially Can f 2, should be considered in further studies.
© 2007 S. Karger AG, Basel
- Platts-Mills TAE, Vervloet D, Thomas WR, Aalberse RC, Chapman MD: Indoor allergens and asthma: report of the third international workshop. J Allergy Clin Immunol 1997;100:S2–S24.
WHO Expert Committee on Biological Standardization: Dog (Canis domesticus) hair and dander extract. World Health Organ Tech Rep Ser 1987;760:19.
- Ford AW, Alterman L, Kemeny DM: The allergens of dog. 1. Identification using crossed radio-immunoelectrophoresis. Clin Exp Allergy 1989;19:183–190.
- Spitzauer S, Schweiger C, Anrather J, Ebner C, Scheiner O, Kraft D, Rumpold H: Characterisation of dog allergens by means of immunoblotting. Int Arch Allergy Immunol 1993;100:60–67.
- Ford AW, Kemeny DM: The allergens of dog. 2. Identification and partial purification of a major dander allergen. Clin Exp Allergy 1992;22:793–803.
- de Groot H, Goei KGH, van Swieten P, Aalberse RC: Affinity purification of a major and a minor allergen from dog extract: serologic activity of affinity-purified Can f 1 and of Can f 1-depleted extract. J Allergy Clin Immunol 1991;87:1056–1065.
- Schou C, Svendsen UG, Løwenstein H: Purification and characterization of the major dog allergen, Can f 1. Clin Exp Allergy 1991;21:321–328.
- Saarelainen S, Taivainen A, Rytkönen-Nissinen M, Auriola S, Immonen A, Mäntyjärvi R, Rautiainen J, Kinnunen T, Virtanen T: Assessment of recombinant dog allergens Can f 1 and Can f 2 for the diagnosis of dog allergy. Clin Exp Allergy 2004;34:1576–1582.
- Konieczny A, Morgenstern JP, Bizinkauskas CB, Lilley CH, Brauer AW, Bond JF, Aalberse RC, Wallner BP, Kasaian MT: The major dog allergens, Can f 1 and Can f 2, are salivary lipocalin proteins: cloning and immunological characterization of the recombinant forms. Immunology 1997;92:577–586.
- Schou C, Hansen GN, Lintner T, Løwenstein H: Assay for the major dog allergens, Can f 1: investigation of house dust samples and commercial dog extracts. J Allergy Clin Immunol 1991;88:847–853.
- Sakaguchi M, Inouye S, Irie T, Miyazawa H, Watanabe M, Yasueda H, Shida T, Nitta H, Chapman MD, Schou C, Aalberse RC: Airborne cat (Fel d 1), dog (Can f 1), and mite (Der I and Der II) allergen levels in the homes of Japan. J Allergy Clin Immunol 1993;92:797–802.
- Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–254.
- Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680–685.
- Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350–4354.
- Matsuoka K, Taya C, Kubo S, Toyama-Sorimachi N, Kitamura F, Ra C, Yonekawa H, Karasuyama H: Establishment of antigen-specific IgE transgenic mice to study pathological and immunological roles of IgE in vivo. Int Immunol 1999;11:987–994.
- Moon PD, Na HJ, Jeong HJ, Hong SH, Kim SJ, Chae HJ, Kim HR, Choi JO, Lee SH, Shin JY, Kim HM: Inhibitory effect of Gamibojungikgitang extract on mast cell-mediated allergic reaction in murine model. J Pharm Pham Sci 2005;8:94–101.
- Tada N, Saka M, Ueda Y, Hoshi H, Uemura T, Kamata Y: Comparative analyses of serum vitellogenin levels in male and female Reeves’ pond turtles (Chinemys reevesii) by an immunological assay. J Comp Physiol B 2004;174:13–20.
Barber RD, Harmer DW, Coleman RA, Clark BJ: GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues. Physiol Genomics 2005;11:389–395.
- Custovic A, Green R, Fletcher A, Smith A, Pickering CA, Chapman MD, Woodcock A: Aerodynamic properties of the major dog allergen Can f 1: distribution in homes, concentration, and particle size of allergen in the air. Am J Respir Crit Care Med 1997;155:94–98.
- Immonen A, Farci S, Taivainen A, Partanen J, Pouvelle-Moratille S, Närvänen A, Kinnunen T, Saarelainen S, Rytkönen-Nissinen M, Maillere B, Virtanen T: T cell epitope-containing peptides of the major dog allergen Can f 1 as candidates for allergen immunotherapy. J Immunol 2005;175:3614–3620.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.